D2-like dopamine receptors mediate the response to amphetamine in a mouse model of ADHD

D2-like dopamine receptors mediate the response to amphetamine in a mouse model of ADHD

The mechanisms underlying the effects of psychostimulants in attention deficit hyperactivity disorder (ADHD) are not well understood, but indirect evidence implicates D2 dopamine receptors. Here we dissect the components of dopaminergic neurotransmission in the hyperactive mouse mutant coloboma to i...

Full description

Bibliographic Details
Main Authors:	Xueliang Fan, Ellen J. Hess
Format:	Article
Language:	English
Published:	Elsevier 2007-04-01
Series:	Neurobiology of Disease
Subjects:	Hyperactivity Coloboma Dopamine receptor Amphetamine ADHD Microdialysis
Online Access:	http://www.sciencedirect.com/science/article/pii/S096999610600324X

Similar Items

Glycogen synthase kinase-3β inhibition in the medial prefrontal cortex mediates paradoxical amphetamine action in a mouse model of ADHD
by: Yi-Chun eYen, et al.
Published: (2015-03-01)

Prolonged Amphetamine Exposures Increase the Endogenous Human Dopamine Receptors 2 at the Cellular Membrane in Cells Lacking the Dopamine Transporter
by: Vindhya Nawaratne, et al.
Published: (2021-08-01)

Assessing Palatability of a New Amphetamine Extended-Release Tablet Formulation for the Treatment of ADHD
by: Pardo A, et al.
Published: (2021-07-01)

Insights into the modulation of dopamine transporter function by amphetamine, orphenadrine and cocaine binding
by: Mary Hongying Cheng, et al.
Published: (2015-06-01)

Amphetamine Promotes Cortical Up State in Part Via Dopamine Receptors
by: Guofang Shen, et al.
Published: (2021-08-01)

Methamphetamine-induced changes in the striatal dopamine pathway in μ-opioid receptor knockout mice
by: Park Sang Won, et al.
Published: (2011-11-01)

Dopamine Receptor Availability in ADHD
by: J Gordon Millichap
Published: (2002-01-01)

Dopamine D2-Subtype Receptors Outside the Blood-Brain Barrier Mediate Enhancement of Mesolimbic Dopamine Release and Conditioned Place Preference by Intravenous Dopamine
by: J. Daniel Obray, et al.
Published: (2022-07-01)

Effectiveness and safety of amphetamine for ADHD in population between 6 and 19 years: a systematic review
by: José Calleja, et al.
Published: (2012-09-01)

Silencing of Syntaxin 1A in the Dopaminergic Neurons Decreases the Activity of the Dopamine Transporter and Prevents Amphetamine-Induced Behaviors in C. elegans
by: Ambra Lanzo, et al.
Published: (2018-05-01)

Reassessment of amphetamine- and phencyclidine-induced locomotor hyperactivity as a model of psychosis-like behavior in rats
by: Snezana Kusljic, et al.
Published: (2022-01-01)

Chronic exposure to a gambling-like schedule of reward predictive stimuli can promote sensitization to amphetamine in rats
by: Martin eZack, et al.
Published: (2014-02-01)

Alterations of Amphetamine Reward by Prior Nicotine and Alcohol Treatment: The Role of Age and Dopamine
by: Andrea Stojakovic, et al.
Published: (2021-03-01)

Altered Grooming Syntax and Amphetamine-Induced Dopamine Release in EAAT3 Overexpressing Mice
by: Angélica P. Escobar, et al.
Published: (2021-06-01)

Preferential Effects of Cariprazine on Counteracting the Disruption of Social Interaction and Decrease in Extracellular Dopamine Levels Induced by the Dopamine D3 Receptor Agonist, PD-128907 in Rats: Implications for the Treatment of Negative and Depressive Symptoms of Psychiatric Disorders
by: Jan Kehr, et al.
Published: (2022-01-01)

Effect of D-amphetamine on dopaminergic neurons of substantia nigra and expression of tyrosine hydroxylase in striatum and pre-frontal cortex of D-amphetamine treated Wistar rats
by: Sarun Koirala, et al.
Published: (2014-10-01)

The Therapeutic Potential of Amphetamine-like Psychostimulants
by: Bruno Pires, et al.
Published: (2023-11-01)

Rise, and pronounced regional variation, in methylphenidate, amphetamine, and lisdexamfetamine distribution in the United States
by: Sneha M. Vaddadi, et al.
Published: (2021-12-01)

Effects of Lisdexamfetamine, a Prodrug of D-Amphetamine, on Locomotion, Spatial Cognitive Processing and Neurochemical Profiles in Rats: A Comparison With Immediate-Release Amphetamine
by: Chen Jian-min, et al.
Published: (2022-04-01)

Amphetamines in child medicine: a review of ClinicalTrials.gov
by: Samer O. Alalalmeh, et al.
Published: (2023-10-01)

Long-Lasting Epigenetic Changes in the Dopamine Transporter in Adult Animals Exposed to Amphetamine during Embryogenesis: Investigating Behavioral Effects
by: Tao Ke, et al.
Published: (2023-08-01)

Crosstalk Between Kappa Opioid and Dopamine Systems in Compulsive Behaviors
by: Angélica del Pilar Escobar, et al.
Published: (2020-02-01)

Finding the “Sweet Spot”: Sharing the decision-making in ADHD treatment selection
by: Daniel Tan, et al.
Published: (2022-05-01)

DRD1 and DRD2 Receptor Polymorphisms: Genetic Neuromodulation of the Dopaminergic System as a Risk Factor for ASD, ADHD and ASD/ADHD Overlap
by: Maria Addolorata Mariggiò, et al.
Published: (2021-09-01)

Altered Accumbal Dopamine Terminal Dynamics Following Chronic Heroin Self-Administration
by: Brianna E. George, et al.
Published: (2022-07-01)

A role for accumbal glycine receptors in modulation of dopamine release by the glycine transporter-1 inhibitor Org25935
by: Helga eHöifödt Lidö, et al.
Published: (2011-03-01)

Trihexyphenidyl rescues the deficit in dopamine neurotransmission in a mouse model of DYT1 dystonia
by: Anthony M. Downs, et al.
Published: (2019-05-01)

The α2C-adrenergic receptor mediates hyperactivity of coloboma mice, a model of attention deficit hyperactivity disorder
by: Kristy J. Bruno, et al.
Published: (2006-09-01)

Adult ADHD in the Republic of Ireland: the evolving response
by: Shaeraine Raaj, et al.

Quetiapine and buspirone both elevate cortical levels of noradrenaline and dopamine in vivo, but do not have synergistic effects
by: Peter H Silverstone, et al.
Published: (2012-09-01)

The Importance of Ventral Hippocampal Dopamine and Norepinephrine in Recognition Memory
by: Joep Titulaer, et al.
Published: (2021-04-01)

Baicalin regulates the dopamine system to control the core symptoms of ADHD
by: Rongyi Zhou, et al.
Published: (2019-02-01)

Relationship of Dopamine of the Nucleus Accumbens with Intra-infralimbic Apomorphine Microinjection
by: Abbas Alimoradian, et al.
Published: (2013-06-01)

Enhanced extracellular glutamate and dopamine in the ventral pallidum of alcohol-preferring AA and alcohol-avoiding ANA rats after morphine
by: Heidi eKemppainen, et al.
Published: (2015-01-01)

Modification of dopamine neurotransmission in the nucleus accumbens of rats deficient in n–3 polyunsaturated fatty acids
by: Luc Zimmer, et al.
Published: (2000-01-01)

The amphetamines use: the truck drivers of vision
by: S. R. O. Maier, et al.
Published: (2018-08-01)

The amphetamines use: the truck drivers of vision
by: S. R. O. Maier, et al.
Published: (2018-08-01)

Viloxazine Increases Extracellular Concentrations of Norepinephrine, Dopamine, and Serotonin in the Rat Prefrontal Cortex at Doses Relevant for the Treatment of Attention-Deficit/Hyperactivity Disorder
by: Garcia-Olivares J, et al.
Published: (2024-01-01)

Involvement of muscarinic receptors in psychomotor hyperactivity in dopamine-deficient mice
by: Masayo Fujita, et al.
Published: (2022-11-01)

Using rodent data to elucidate dopaminergic mechanisms of ADHD: Implications for human personality
by: Gail Tripp, et al.
Published: (2024-01-01)